At a glance
ClinicalIndex Comparison RecordN/ACompleted· 64 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Monitoring CD64 on Neutrophils Regarding Effects of Antibiotics in Patients With SIRS Developing Sepsis
In Brief
An observational study for Antibiotic Resistant Infection and 3 related conditions. Completed, enrolled 64 participants across 1 site.
Detailed Summary
The purpose of the study is to find out whether CD64 expression on neutrophils measured by a new bedside test (LeukoDx) within 30 minutes is associated with effective antibiotic therapy in critically ill adult patients at risk of sepsis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAntibiotic Resistant Infection, Critical Illness, SIRS, Sepsis
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedOct 2016
Primary CompletionDec 2019
Study CompletionJun 2021
TodayJul 2026
First PostedOct 4, 2016
Enrollment StartSep 1, 2016
Primary CompletionDec 31, 2019
Study CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 9.7 years ago